Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Immunotherapy|April 28, 2021
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
International Journal of Molecular Sciences|January 8, 2025
Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric CancerEmanuele Piccinno, Annalisa Schirizzi, Viviana Scalavino, et al.
Anticancer Research|June 4, 2020
Second-line Treatment in Advanced Biliary Tract Cancer: Today and TomorrowAlessandro Rizzo, Angela Dalia Ricci, Nastassja Tober, et al.
In Vivo (Athens, Greece)|November 4, 2020
The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular CarcinomaAngela Dalia Ricci, Alessandro Rizzo, Chiara Bonucci, et al.
International Journal of Molecular Sciences|July 27, 2024
Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic ImplicationsCarmelo Laface, Angela Dalia Ricci, Simona Vallarelli, et al.
Cancers|February 4, 2021
Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the ArtVeronica Mollica, Alessandro Rizzo, Matteo Rosellini, et al.
Anticancer Research|February 5, 2020
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysisAngela Dalia Ricci, Alessandro Rizzo, Marco Novelli, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of CholangiocarcinomaAndrea Palloni, Silvia Bisello, Ilaria Maggio, et al.
Cancers|April 26, 2025
Unravelling Paclitaxel Resistance in Gastric Cancer: The Role of Small Extracellular Vesicles in Epithelial Mesenchymal Transition and Extracellular Matrix RemodellingGiorgia Panzetta, Annalisa Schirizzi, Francesco Balestra, et al.
Cancers|May 16, 2023
Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research AvenuesAnnalisa Schirizzi, Giampiero De Leonardis, Vincenza Lorusso, et al.
Pageof 9